BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 9, 2009
View Archived Issues
Regulatory Submissions Data System Integration: How to Do it
Read More
NewCo News: Kinaris Targeting Myosins with Allosteric Inhibitors
Read More
Other News To Note
Read More
Financings Roundup
Read More
Clinic Roundup
Read More
Appointments And Advancements
Read More
Opexa Gets Boost on Positive Analysis of Tovaxin MS Data
Shares of Opexa Therapeutics Inc. soared 270 percent Tuesday on news of a positive complete analysis of its Phase IIb drug for multiple sclerosis, Tovaxin. (BioWorld Today)
Read More
Osiris Sees Prochymal Promise Despite Phase III GvHD Failures
Read More